Publicacións nas que colabora con Javier de la Rubia Comos (25)

2022

  1. Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia

    Bone Marrow Transplantation, Vol. 57, Núm. 9, pp. 1389-1398

2019

  1. Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma

    Annals of Hematology

2017

  1. Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis

    Neurological Sciences, Vol. 38, Núm. 7, pp. 1213-1221

2013

  1. Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Matched Comparison to a Melphalan-Only Approach

    Biology of Blood and Marrow Transplantation, Vol. 19, Núm. 1, pp. 69-74

2009

  1. Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study

    Haematologica, Vol. 94, Núm. 9, pp. 1282-1288

  2. Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: A phase II trial

    Leukemia and Lymphoma, Vol. 50, Núm. 2, pp. 216-222

2007

  1. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors

    Blood, Vol. 110, Núm. 1, pp. 461-467

2002

  1. Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34 + selected blood cells from HLA-identical siblings

    Blood, Vol. 100, Núm. 2, pp. 724-727

2001

  1. Allogeneic transplantation of CD34+ -selected cells from peripheral blood in patients with myeloid malignancies in early phase: A case control comparison with unmodified peripheral blood tranplantation

    Bone Marrow Transplantation, Vol. 28, Núm. 4, pp. 349-354

  2. Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies

    British Journal of Haematology, Vol. 114, Núm. 3, pp. 544-550

  3. Severe infections after allogeneic peripheral blood stem cell transplantation: A matched-pair comparison of unmanipulated and CD34+ cell-selected transplantation

    Haematologica, Vol. 86, Núm. 10, pp. 1075-1086

  4. The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings

    Blood, Vol. 97, Núm. 2, pp. 383-387

2000

  1. Are myeloma patients with renal failure candidates for autologous stem cell transplantation?

    Hematology Journal, Vol. 1, Núm. 1, pp. 28-36

  2. The number of donor CD34+ and CD3+ cells is the most important factor for disease free survival after allogeneic transplantation of CD34+ selected cells from peripheral blood (allo-PBT/CD34+) from HLA-identical siblings

    Hematology and Cell Therapy

  3. The number of donor cd3+ cells is the most important factor for graft failure after allogeneic transplantation of cd34+ selected cells from peripheral blood (allo-pbt/cd34+) from hla-identical siblings

    Blood, Vol. 96, Núm. 11 PART II

1999

  1. Administration of recombinant human granulocyte colony-stimulating factor to normal donors: Results of the Spanish National Donor Registry

    Bone Marrow Transplantation, Vol. 24, Núm. 7, pp. 723-728

1998

  1. Allogeneic transplantation of purified CD34+ cells from peripheral blood: Spanish experience of 62 cases

    Bone Marrow Transplantation

  2. Allogeneic transplantation of selected CD34+ cells from peripheral blood: Experience of 62 cases using immunoadsorption or immunomagnetic technique

    Bone Marrow Transplantation, Vol. 22, Núm. 6, pp. 519-525

  3. Autologous peripheral blood stem cell transplantation for multiple myeloma: A report of 259 cases from the Spanish Registry

    Bone Marrow Transplantation, Vol. 21, Núm. 2, pp. 133-140

1997

  1. High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation

    Haematologica, Vol. 82, Núm. 6, pp. 683-689